Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingThis study tests an experimental drug called centhaquine in 80 adults with moderate to severe ARDS, a life-threatening lung condition. The drug is added to standard care to see if it improves oxygen levels and reduces deaths. Participants must be in the ICU and start treatment wi…
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to save lives from shock due to blood loss
Disease control Not yet recruitingThis study tests a new medicine called centhaquine for people in hypovolemic shock, a life-threatening condition where the body doesn't have enough blood flow. About 430 adults will receive either centhaquine or a placebo along with standard care. The main goal is to see if the d…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC